TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP December 30, 2005
TCL Archive Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement July 25, 2013
